For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Hamilton, Ontario N2M 5N6

0 studies enrolling now · 12 studies all time

What they study most

Arthritis, Rheumatoid, Autoimmune Disease, Back Pain, Cardiovascular Disease, Cardiovascular Diseases, Connective Tissue Disease, Diabetes Mellitus, Type 2, Melanoma, Non Hodgkin Lymphoma, Non-small Cell Lung Cancer, Osteoporosis, Postmenopausal, Postmenopausal Osteoporosis

Studies at this site

• A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2) — Completed
• Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) — Completed
• A Study of Evacetrapib in High-Risk Vascular Disease — Stopped early
• VERtebral Fracture Treatment Comparisons in Osteoporotic Women — Completed
• A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor Therapy — Completed
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin — Completed
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus — Completed
• A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
• An Open Label Extension Study in Participants With Rheumatoid Arthritis — Completed
• A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung Cancer — Completed
• A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes — Completed
• Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis — Completed